Schedule 13G ownership disclosure
OYSTER POINT PHARMA INC
Security class unavailable · CUSIP: 69242L106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,295,000
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000693
- Form type
- SC 13G
- Filer
- Oyster Point Pharma, Inc.
- CIK
- CIK 1720725
- Filed
- Oct 28, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership